T. Rowe Price Associates’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

T. Rowe Price Associates’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,331	Closed	-$253K	–	2552
2020 Q1	$253K	Hold	7,331	–	–	﹤0.01%	2247
2019 Q4	$243K	Buy	+7,331	New	+$219K	﹤0.01%	2373

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates's ZEAL Position: Q2 2020 in Review

T. Rowe Price Associates sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q2 2020, closing a stake of 7,331 shares — an estimated $253K sold.

T. Rowe Price Associates first reported a position in ZEAL in Q4 2019 and held it in 2 quarters. The position peaked at $253K in Q1 2020. 16 funds tracked by Wall St. Rank hold ZEAL as of Q2 2020.

T. Rowe Price Associates reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q2 2020 after selling out during the quarter.
T. Rowe Price Associates sold 7,331 Zealand Pharma A/S American Depositary Shares shares in Q2 2020, an estimated $253K.
T. Rowe Price Associates first reported a position in Zealand Pharma A/S American Depositary Shares in Q4 2019 and held it in 2 quarters.
T. Rowe Price Associates's Zealand Pharma A/S American Depositary Shares position peaked at $253K in Q1 2020.
16 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q2 2020.

Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.